Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 1606 participants.
Also called NCT01385319
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,606 participants
- Sponsor
- Marco Valgimigli
- Registry
-
NCT01385319
-
- Other papers using this trial's data
- Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial
- Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Hungary, Italy, Portugal, Switzerland
- Registry status
- Unknown status
Technical summary
Registry record NCT01385319. Randomized; single masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study
- Acronym
- ZEUS
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Bare metal stent implantation
- Intervention (Device)
- zotarolimus eluting stent
- Lead sponsor
- Marco Valgimigli
Record details
- Record id
cardio:ct-nct01385319- Content hash
e8805a583e1299e9ab42e494e1c3cd39ffc697a2f21f1925545b3e90180129c7